AtriCure Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . AtriCure
ATRC Stock  USD 39.27  0.29  0.73%   
AtriCure's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing AtriCure's valuation are provided below:
Gross Profit
388.1 M
Profit Margin
(0.06)
Market Capitalization
2 B
Enterprise Value Revenue
3.6574
Revenue
518.3 M
We have found one hundred twenty available fundamental signals for AtriCure, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of AtriCure's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. As of January 4, 2026, Market Cap is expected to decline to about 60.5 M. In addition to that, Enterprise Value is expected to decline to about 55.2 M

AtriCure Total Revenue

561.86 Million

Check AtriCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AtriCure's main balance sheet or income statement drivers, such as Interest Expense of 7.7 M, Total Revenue of 561.9 M or Gross Profit of 419.6 M, as well as many indicators such as Price To Sales Ratio of 3.37, Dividend Yield of 0.0 or PTB Ratio of 3.71. AtriCure financial statements analysis is a perfect complement when working with AtriCure Valuation or Volatility modules.
  
Build AI portfolio with AtriCure Stock
Check out the analysis of AtriCure Correlation against competitors.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

AtriCure Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets735.8 M700.7 M390.9 M
Slightly volatile
Total Stockholder Equity556.6 M530.1 M271.5 M
Slightly volatile
Common Stock Shares Outstanding56.7 M54 M34.2 M
Slightly volatile
Liabilities And Stockholders Equity735.8 M700.7 M390.9 M
Slightly volatile
Other Stockholder Equity1 B993.3 M521.5 M
Slightly volatile
Total Liabilities179.1 M170.6 M119.5 M
Slightly volatile
Other Current Liabilities55 M52.4 M25.6 M
Slightly volatile
Total Current Liabilities88.7 M84.4 M43.8 M
Slightly volatile
Accounts Payable30.2 M28.8 M14.7 M
Slightly volatile
Cash148.2 M141.1 M49.5 M
Slightly volatile
Inventory91 M86.6 M34.6 M
Slightly volatile
Other Current Assets11.4 M10.8 M4.5 M
Slightly volatile
Common Stock29.3 K56.4 K34.5 K
Slightly volatile
Property Plant Equipment51.5 M49 M27.5 M
Slightly volatile
Property Plant And Equipment Net57.2 M54.5 M29.1 M
Slightly volatile
Non Current Assets Total412.4 M392.7 M235.1 M
Slightly volatile
Non Currrent Assets Other3.5 M3.3 M1.1 M
Slightly volatile
Cash And Short Term Investments148.2 M141.1 M86.5 M
Slightly volatile
Net Receivables72.9 M69.4 M30.9 M
Slightly volatile
Common Stock Total Equity28.2 K54 K34.1 K
Slightly volatile
Non Current Liabilities Total61.1 M86.2 M76.2 M
Slightly volatile
Property Plant And Equipment Gross131.2 M125 M44.2 M
Slightly volatile
Total Current Assets323.4 M308 M156.5 M
Slightly volatile
Short and Long Term Debt Total92.4 M88 M47.2 M
Slightly volatile
Long Term Debt74.7 M71.1 M36 M
Slightly volatile
Good Will283.5 M270 M144.6 M
Slightly volatile
Short Term Debt2.6 M3.2 M2.8 M
Slightly volatile
Intangible Assets38.1 M64.9 M46.7 M
Slightly volatile
Other Liabilities1.3 M1.4 M31.4 M
Very volatile
Current Deferred Revenue978.9 K797.4 K1.1 M
Slightly volatile
Long Term Debt Total34.9 M65.4 M35.3 M
Slightly volatile
Capital Surpluse470.9 M905.5 M482.8 M
Slightly volatile
Non Current Liabilities Other1.3 M1.4 M34.7 M
Very volatile
Short and Long Term Debt3.2 M2.5 M3 M
Pretty Stable
Capital Lease Obligations10.3 M10.7 M12.8 M
Slightly volatile
Net Invested Capital463.5 M604.5 M337.6 M
Slightly volatile
Net Working Capital167.5 M223.6 M115.4 M
Slightly volatile
Capital Stock49.3 K56.4 K43 K
Slightly volatile

AtriCure Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue561.9 M535.1 M234.6 M
Slightly volatile
Gross Profit419.6 M399.7 M173.4 M
Slightly volatile
Other Operating Expenses610.2 M581.1 M256.3 M
Slightly volatile
Cost Of Revenue142.2 M135.5 M61.2 M
Slightly volatile
Total Operating Expenses468 M445.7 M195.1 M
Slightly volatile
Income Tax Expense868.4 K921.6 K483.4 K
Very volatile
Selling General Administrative351.8 M335.1 M145.2 M
Slightly volatile
Research Development116.1 M110.6 M45.6 M
Slightly volatile
Depreciation And Amortization22.6 M21.5 M9.6 M
Slightly volatile
Tax Provision1.2 M1.2 M311.4 K
Slightly volatile
Interest Income5.4 M5.1 M1.7 M
Slightly volatile
Reconciled Depreciation12.7 M21.5 M11.2 M
Slightly volatile
Non Recurring65.8 M74.1 M80.8 M
Slightly volatile

AtriCure Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures28.3 M27 M13.4 M
Slightly volatile
End Period Cash Flow148.2 M141.1 M49.5 M
Slightly volatile
Begin Period Cash Flow101.8 M97 M37.2 M
Slightly volatile
Depreciation22.6 M21.5 M9.6 M
Slightly volatile
Stock Based Compensation48.8 M46.5 M20 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.373.5577.8006
Slightly volatile
PTB Ratio3.712.85.487
Slightly volatile
Days Sales Outstanding56.9654.4351.4309
Slightly volatile
Book Value Per Share9.288.836.5108
Slightly volatile
Average Payables2 M3.7 M3.7 M
Very volatile
Stock Based Compensation To Revenue0.05730.08050.0738
Slightly volatile
Capex To Depreciation2.682.551.6746
Slightly volatile
PB Ratio3.712.85.487
Slightly volatile
EV To Sales3.263.4377.8015
Slightly volatile
Inventory Turnover2.621.82.3103
Slightly volatile
Days Of Inventory On Hand133210172
Slightly volatile
Payables Turnover4.415.414.252
Very volatile
Sales General And Administrative To Revenue0.780.740.6782
Very volatile
Average Inventory3.8 M5.5 M5.7 M
Pretty Stable
Research And Ddevelopement To Revenue0.220.240.1948
Pretty Stable
Capex To Revenue0.04360.04540.0575
Pretty Stable
Cash Per Share1.742.352.2524
Slightly volatile
Days Payables Outstanding10989.2193.422
Very volatile
Intangibles To Total Assets0.260.430.3935
Slightly volatile
Current Ratio3.814.193.387
Slightly volatile
Receivables Turnover5.746.947.188
Slightly volatile
Shareholders Equity Per Share9.288.836.5108
Slightly volatile
Debt To Equity0.150.1660.2015
Pretty Stable
Capex Per Share0.250.450.3657
Very volatile
Average Receivables4.8 M7.5 M7.7 M
Pretty Stable
Revenue Per Share9.368.925.7968
Slightly volatile
Interest Debt Per Share1.671.591.2246
Slightly volatile
Debt To Assets0.0880.110.1164
Very volatile
Graham Number13.1214.7616.1126
Slightly volatile
Operating Cycle175253222
Slightly volatile
Price Book Value Ratio3.712.85.487
Slightly volatile
Days Of Payables Outstanding10989.2193.422
Very volatile
Ebt Per Ebit0.840.981.0557
Slightly volatile
Company Equity Multiplier1.11.191.5501
Slightly volatile
Long Term Debt To Capitalization0.0880.110.125
Pretty Stable
Total Debt To Capitalization0.120.130.1561
Pretty Stable
Debt Equity Ratio0.150.1660.2015
Pretty Stable
Quick Ratio3.163.012.7209
Slightly volatile
Net Income Per E B T1.111.181.0222
Slightly volatile
Cash Ratio1.281.921.0023
Slightly volatile
Cash Conversion Cycle95.64183131
Slightly volatile
Days Of Inventory Outstanding133210172
Slightly volatile
Days Of Sales Outstanding56.9654.4351.4309
Slightly volatile
Price To Book Ratio3.712.85.487
Slightly volatile
Fixed Asset Turnover12.2911.2910.1698
Slightly volatile
Debt Ratio0.0880.110.1164
Very volatile
Price Sales Ratio3.373.5577.8006
Slightly volatile
Asset Turnover0.940.880.7464
Pretty Stable
Gross Profit Margin0.580.670.7096
Very volatile
Price Fair Value3.712.85.487
Slightly volatile

AtriCure Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap60.5 M79.2 M82.1 M
Pretty Stable
Enterprise Value55.2 M75.6 M78.3 M
Pretty Stable

AtriCure Fundamental Market Drivers

AtriCure Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About AtriCure Financial Statements

AtriCure stakeholders use historical fundamental indicators, such as AtriCure's revenue or net income, to determine how well the company is positioned to perform in the future. Although AtriCure investors may analyze each financial statement separately, they are all interrelated. For example, changes in AtriCure's assets and liabilities are reflected in the revenues and expenses on AtriCure's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AtriCure. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue797.4 K978.9 K
Total Revenue535.1 M561.9 M
Cost Of Revenue135.5 M142.2 M
Stock Based Compensation To Revenue 0.08  0.06 
Sales General And Administrative To Revenue 0.74  0.78 
Research And Ddevelopement To Revenue 0.24  0.22 
Capex To Revenue 0.05  0.04 
Revenue Per Share 8.92  9.36 
Ebit Per Revenue(0.08)(0.08)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc
When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:
How To Invest In AtriCure
Details
Is AtriCure Stock a good investment?
Details
What is AtriCure's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of AtriCure Correlation against competitors.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.61)
Revenue Per Share
10.902
Quarterly Revenue Growth
0.158
Return On Assets
(0.03)
Return On Equity
(0.06)
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY